Robustness Testing of Black-Box Models Against CT Degradation Through Test-Time Augmentation

Deep learning models for medical image segmentation and object detection are becoming increasingly available as clinical products. However, as details are rarely provided about the training data, models may unexpectedly fail when cases differ from those in the training distribution. An approach allowing potential users to independently test the robustness of a model, treating it as a black box and using only a few cases from their own site, is key for adoption. To address this, a method to test the robustness of these models against CT image quality variation is presented. In this work we present this framework by demonstrating that given the same training data, the model architecture and data pre processing greatly affect the robustness of several frequently used segmentation and object detection methods to simulated CT imaging artifacts and degradation. Our framework also addresses the concern about the sustainability of deep learning models in clinical use, by considering future shifts in image quality due to scanner deterioration or imaging protocol changes which are not reflected in a limited local test dataset.

Disease classification of macular Optical Coherence Tomography scans using deep learning software: validation on independent, multi-centre data

Purpose: To evaluate Pegasus-OCT, a clinical decision support software for the identification of features of retinal disease from macula OCT scans, across heterogenous populations involving varying patient demographics, device manufacturers, acquisition sites and operators. Methods: 5,588 normal and anomalous macular OCT volumes (162,721 B-scans), acquired at independent centres in five countries, were processed using the software. Results were evaluated against ground truth provided by the dataset owners. Results: Pegasus-OCT performed with AUROCs of at least 98% for all datasets in the detection of general macular anomalies. For scans of sufficient quality, the AUROCs for general AMD and DME detection were found to be at least 99% and 98%, respectively. Conclusions: The ability of a clinical decision support system to cater for different populations is key to its adoption. Pegasus-OCT was shown to be able to detect AMD, DME and general anomalies in OCT volumes acquired across multiple independent sites with high performance. Its use thus offers substantial promise, with the potential to alleviate the burden of growing demand in eye care services caused by retinal disease.